Literature DB >> 15013861

Optic radiation involvement in optic pathway gliomas in neurofibromatosis.

Grant T Liu1, Michael C Brodsky, Peter C Phillips, Jean Belasco, Anna Janss, Jeffrey C Golden, Larissa L Bilaniuk, G Timothy Burson, Ann-Christine Duhaime, Leslie N Sutton.   

Abstract

PURPOSE: Optic pathway gliomas (pilocytic astrocytomas) in neurofibromatosis type 1 (NF-1) typically involve some combination of the optic nerves, chiasm, or optic tracts. Involvement of the optic radiations is rare.
DESIGN: This paper describes seven patients with NF-1 with gliomas involving the pregeniculate optic pathway in addition to the optic radiations.
METHODS: A retrospective database review was made of all patients with NF-1 and optic pathway gliomas seen by one of the authors (G.T.L.) at the Children's Hospital of Philadelphia from July 1993 to October 2001. Patients with involvement of pregeniculate optic pathway and the optic radiations were identified. From November 2001 to February 2003, patients were sought prospectively. Cases were also identified from the practice of another author (M.C.B.) at Arkansas Children's Hospital.
RESULTS: Four patients from Children's Hospital of Philadelphia (three of 83 total NF-1/optic pathway gliomas from July 1993 to October 2001 and one prospectively) and three from Arkansas Children's Hospital were identified. Two had expanding mass lesions within the white matter of the temporal or parietal lobes, which were histopathologically demonstrated to be pilocytic astrocytomas. The other five had radiographic involvement of the optic radiations but did not undergo biopsy. In three of the cases the vision was 20/200 or worse in each eye.
CONCLUSIONS: Optic pathway gliomas in NF-1 may rarely involve the optic radiations. Optic radiation involvement may signal a more aggressive optic pathway glioma in patients with neurofibromatosis-1.

Entities:  

Mesh:

Year:  2004        PMID: 15013861     DOI: 10.1016/j.ajo.2003.09.055

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

Review 1.  Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature.

Authors:  Manolo Piccirilli; Jacopo Lenzi; Catia Delfinis; Guido Trasimeni; Maurizio Salvati; Antonino Raco
Journal:  Childs Nerv Syst       Date:  2006-04-26       Impact factor: 1.475

Review 2.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

3.  Optic pathway gliomas in adolescence--time to challenge treatment choices?

Authors:  Amy Lee Chong; Jason D Pole; Katrin Scheinemann; Juliette Hukin; Uri Tabori; Annie Huang; Eric Bouffet; Ute Bartels
Journal:  Neuro Oncol       Date:  2013-01-07       Impact factor: 12.300

4.  Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome.

Authors:  I A Chaudhry; J Morales; F A Shamsi; W Al-Rashed; E Elzaridi; Y O Arat; C Jacquemin; D T Oystreck; T M Bosley
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

Review 5.  Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.

Authors:  Morgan E Freret; David H Gutmann
Journal:  J Neurosci Res       Date:  2018-04-28       Impact factor: 4.164

Review 6.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

Review 7.  Ophthalmological assessment of children with neurofibromatosis type 1.

Authors:  Catherine Cassiman; Eric Legius; Werner Spileers; Ingele Casteels
Journal:  Eur J Pediatr       Date:  2013-05-25       Impact factor: 3.183

8.  Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.

Authors:  Michael J Wan; Nicole J Ullrich; Peter E Manley; Mark W Kieran; Liliana C Goumnerova; Gena Heidary
Journal:  J Neurooncol       Date:  2016-06-16       Impact factor: 4.130

9.  Prior surgical intervention and tumor size impact clinical outcome after precision radiotherapy for the treatment of optic nerve sheath meningiomas (ONSM).

Authors:  Sebastian Adeberg; Thomas Welzel; Stefan Rieken; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2011-09-18       Impact factor: 3.481

10.  A case of neurofibromatosis 1 presenting with optic pathway glioma with an early onset and an aggressive course.

Authors:  Suma Ganesh; Archana Gupta; Manish Sharma; Sandeep Bhuttan
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.